Bitter Pill? Pharma Restructuring Challenges …and Upside

This diverse panel will explore the unique and challenging aspects of pharmaceutical restructurings.

Pharmaceutical businesses can experience many disorders – from wholesalers to prescription benefit managers, to regulators, the industry often suffers from maladies not seen in other sectors. Add expiring patent protections, the opioid crisis and pricing pressures and the formula for recovery can be difficult. Despite these ailments, the panel will share their real-life experiences with alternative strategies and some prescriptions for extracting value.

Read more: 35th Annual Bankruptcy & Restructuring Conference

Sponsor: Association of Insolvency & Restructuring Advisors (AIRA)


Back To Listing